Back to Search Start Over

4507 ORAL Axitinib (AG-013736; AG) in patients (pts) with metastatic clear cell renal cell cancer (RCC) refractory to sorafenib.

Authors :
Rini, B.
Wilding, G.
Hudes, G.
Stadler, W.M.
Kim, S.
Tarazi, J.
Bycott, P.
Liau, K.
Dutcher, J.
Source :
EJC Supplements; Aug2007, Vol. 5 Issue 4, p300-300, 1p
Publication Year :
2007

Details

Language :
English
ISSN :
13596349
Volume :
5
Issue :
4
Database :
Supplemental Index
Journal :
EJC Supplements
Publication Type :
Academic Journal
Accession number :
27457238
Full Text :
https://doi.org/10.1016/S1359-6349(07)71138-2